World's First Experience of the Low-Dose Radionuclide Inhalation Therapy in the Treatment of COVID-19-Associated Viral Pneumonia: Phase 1/2 Clinical Trial.
Shegay P, Leontyev A, Baranovskii D, Davydov G, Poluektova M, Grivtsova L, Petriev V, Stepanenko V, Gulidov I, Krylov V, Osadchaya S, Petrov V, Sedova M, Vekilyan M, Krasilnikova O, Morozov S, Ivanov S, Klabukov I, Kaprin A.
Shegay P, et al. Among authors: krasilnikova o.
Curr Radiopharm. 2023 Jun 5;16(3):243-252. doi: 10.2174/1874471016666230307113045.
Curr Radiopharm. 2023.
PMID: 36880188
Clinical Trial.